Cargando…

Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?

Detalles Bibliográficos
Autor principal: Mangla, Ankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581658/
https://www.ncbi.nlm.nih.gov/pubmed/37441745
http://dx.doi.org/10.1200/GO.23.00110
_version_ 1785122182887636992
author Mangla, Ankit
author_facet Mangla, Ankit
author_sort Mangla, Ankit
collection PubMed
description
format Online
Article
Text
id pubmed-10581658
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-105816582023-10-18 Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries? Mangla, Ankit JCO Glob Oncol Correspondence Wolters Kluwer Health 2023-07-13 /pmc/articles/PMC10581658/ /pubmed/37441745 http://dx.doi.org/10.1200/GO.23.00110 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle Correspondence
Mangla, Ankit
Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
title Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
title_full Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
title_fullStr Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
title_full_unstemmed Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
title_short Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
title_sort should neoadjuvant treatment be adopted more widely for patients with extremity soft tissue sarcoma in low-income countries?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581658/
https://www.ncbi.nlm.nih.gov/pubmed/37441745
http://dx.doi.org/10.1200/GO.23.00110
work_keys_str_mv AT manglaankit shouldneoadjuvanttreatmentbeadoptedmorewidelyforpatientswithextremitysofttissuesarcomainlowincomecountries